News 17 Jun 2026 DNDi and Medicines for Malaria Venture (MMV) pool regulatory expertise to accelerate access to lifesaving medicines
Stories 17 Jun 2026 The DNDi-MMV Joint Regulatory Platform: ‘a pioneering programme project for non-profit medical research organizations to speak with one voice’
Press Releases Translations 12 Jun 2026 La RDC approuve l’utilisation de l’acoziborole, un traitement oral à dose unique contre la maladie du sommeil
Press releases 12 Jun 2026 DRC approves the use of acoziborole, a breakthrough one-day oral treatment against sleeping sickness
Statements 9 Jun 2026 DNDi Statement at the UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR)
Press releases 8 Jun 2026 DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need
Scientific articles 5 Jun 2026 Severe visceral leishmaniasis in Ethiopia: Outcomes, co-infections and mortality in a prospective real-world cohort PLOS Neglected Tropical Diseases
Scientific articles 29 May 2026 From invisibility to political power: Policy lessons from a decade of Brazil’s Social Forum for Infectious and Neglected Diseases PLOS Neglected Tropical Diseases
Scientific articles 14 May 2026 In vitro profiling of Trypanosoma cruzi inhibitors identified from high throughput screening and application to parasite painting International Journal for Parasitology: Drugs and Drug Resistance
Statements 15 May 2026 DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’
Scientific articles 13 May 2026 Chemical genetics reveals Leishmania KKT2 and CRK9 kinase activity is required for cell cycle progression PLOS Pathogens
Press releases 12 May 2026 DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai
In the media 29 Apr 2026 Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure Thai Rath
Press releases 14 Mar 2019 Study shows dramatically shorter treatment for Chagas disease could be just as effective, and significantly safer
Press releases 5 Feb 2019 Wellcome commits £10 million to DNDi to develop new generation of oral drugs to treat leishmaniasis
Press releases 30 Jan 2019 Fexinidazole, the first all-oral treatment for sleeping sickness, approved in Democratic Republic of Congo
Press releases 29 Jan 2019 MMV and DNDi make 400 compounds available to stimulate research into new drugs for pandemic diseases
Press releases 23 Jan 2019 Drugs for Neglected Diseases initiative and The BMJ launch a special collection on neglected diseases and innovation in South Asia
Press releases 17 Jan 2019 Combination therapy found to be more effective in treating patients with leishmaniasis and HIV
Press releases 16 Nov 2018 European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness
Press releases 12 Sep 2018 New hope for PKDL patients in Africa as clinical trial aims to make treatment safer and easier
Press releases 5 Sep 2018 DNDi and Fiocruz launch project to expand access to diagnosis and treatment for Chagas disease in Brazil
Press releases 23 Jul 2018 FIND and DNDi team up to support Malaysian MOH efforts to simplify and decentralize hepatitis C screening & treatment
Press releases 14 Apr 2018 DNDi agreement with Colombia Ministry of Health and Social Welfare to guarantee access to comprehensive care for Chagas patients
Press releases 13 Apr 2018 Clinical trial to find new treatment for visceral leishmaniasis begins in eastern Africa
Press releases 5 Apr 2018 Takeda Pharmaceutical and DNDi collaborate to progress a potential new drug for visceral leishmaniasis through the R&D pipeline
Press releases 27 Mar 2018 DNDi, GlaxoSmithKline, and University of Dundee to identify drug candidates to treat leishmaniasis and Chagas disease
